Barclays Initiates Coverage On Alpha Tau Medical with Overweight Rating, Announces Price Target of $15
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
Barclays analyst Lukas Shumway initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Overweight rating and announces Price Target of $15.
Barclays analyst Lukas Shumway initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Overweight rating and announces Price Target of $15.